The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma

Gynecologic Oncology

Volumn 112, Issue 3, 2009, Pages 511-516

  Neubauer, Nikki L ^a   Havrilesky, Laura J ^a   Calingaert, Brian ^b   Bulusu, Anuradha ^b   Bernardini, Marcus Q ^c   Fleming, Nicole D ^a   Bland, Amy E ^a   Secord, Angeles Alvarez ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Grade 1 endometrial carcinoma; Lymphadenectomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER INVASION; CANCER RISK; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENDOMETRIUM CARCINOMA; FEMALE; HIGH RISK PATIENT; HISTOLOGY; HUMAN; HYSTERECTOMY; INTRAOPERATIVE PERIOD; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; METASTASIS; MYOMETRIUM; PATHOGENESIS; PATIENT IDENTIFICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 60449092019     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.11.012     Document Type: Article

References (14)

1. Creasman W., Morrow C., Bundy B., Homesley H., Graham J., and Heller P. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer 60 (1987) 2035-2041
2. Ben-Shachar I., Pavelka J., Cohn D., Copeland L., Ramirez N., Manolitsas T., et al. Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet. Gynecol. 105 (2005) 487-493
3. Lutman C., Havrilesky L., Cragun J., Secord A., Calingaert B., Berchuck A., et al. Pelvic lymph node count in an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol. Oncol. 102 (2006) 92-97
4. Cohn D., Huh W., Fowler J., and Straughn M. Cost-effective analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma. Obstet. Gynecol. 109 (2007) 1388-1395
5. ACOG Committee on Practice Bulletins. Management of endometrial cancer. 2005; 65: 1-9.
6. Mariani A., Dowdy S., Cliby W., Gostout B., Jones M., Wilson T., et al. Prospective assessment if lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol. Oncol. 109 (2008) 11-18
7. Huh W., Straughn J., Kelly F., and Kilgore L. Endometrial carcinoma. Curr. Treatm. Opt. Oncol. 2 (2001) 129-135
8. Aalders J., and Thomas G. Endometrial cancer - revisiting the importance of pelvic and para aortic lymph nodes. Gynecol. Oncol. 104 (2007) 222-231
9. Cragun J., Havrilesky L., Calingaert B., Synan I., Secord A., Soper J., et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J. Clin. Oncol. 23 (2005) 3668-3675
10. Orr JW, Naumann WR, Escobar P. Attitude is a little thing that makes a big difference. Gynecol Oncol; 109: 147-51.
11. Havrilesky L., Cragun J., Calingaert B., Synan I., Secord A., Soper J., et al. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol. Oncol. 99 (2005) 689-695
12. Kilgore L., Partridge E., Alvarez R., Austin J., Shingleton H., Noojin F., et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol. Oncol. 56 (1995) 29-33
13. Chan J., Kapp D., Cheung M., Shin J., Stieglitz D., Husain A., et al. Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer. Am. J. Obstet. Gynecol. 198 (2008) 216.e1-216.e5
14. Orton J., Blake P., on behalf of ASTEC/EN.5 collaborators. Adjuvant external beam radiotherapy (EBRT) in the treatment of endometrial cancer: results of the randomized MRC ASTEC and NCIC CTG EN.5 trial. Presented at ASCO 2007 43rd annual meeting. 2007.